Growing Incidence of Chronic Diseases Fueling Demand for Biobanks

The rising incidence of various chronic conditions and diseases such as Parkinson’s disease, diabetes, and Alzheimer’s disease is pushing up the demand for stem cells and cord blood cells across the globe, on account of the fact that these therapies can help considerably in organ transplantation, tissue grafting, drug testing, and the development of regenerative medicine. This is subsequently pushing up the requirement for biobanks and biobanking solutions across the world.

Receive Sample Copy of this Report: https://www.psmarketresearch.com/market-analysis/biobanking-market/report-sample

Due to the aforementioned factors, the demand for biobanks is growing rapidly across the world. This is driving the advancement of the global biobanking market. As a result, the valuation of the market is predicted to surge from $25.8 billion in 2018 to $36.8 billion by 2024. Furthermore, the market is predicted to progress at a CAGR of 6.2% between 2019 and 2024. Depending on offering, the market is divided into services, software, equipment, and consumables.

Make an Enquiry before Purchase: https://www.psmarketresearch.com/send-enquiry?enquiry-url=biobanking-market

Hence, it can be said with full confidence that the demand for biobanks will surge all over the world in the coming years, primarily because of the rising incidence of chronic diseases, the soaring geriatric population, and the allocation of huge funds for the development of biobanks in healthcare facilities around the world.